Françoise de Craecker
Director/Miembro de la Junta en X4 PHARMACEUTICALS, INC. .
Fortuna: 97 634 $ al 31/05/2024
Relaciones activas
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Michael Wyzga | M | 69 | 11 años | |
Paula Ragan | M | 54 | 10 años | |
Adam Mostafa | M | 44 | 6 años | |
Gregg Lapointe | M | 65 | 9 años | |
Laurence Rodriguez | F | 56 | 3 años | |
Mary DiBiase | M | 63 | 7 años | |
Kim Lee | M | - | 10 años | |
Paul Hoelscher | M | 59 | 8 años | |
Sissel Rodahl | F | - | 6 años | |
Alison Lawton | F | 62 | 4 años | |
Gary Bridger | M | 61 | 6 años | |
Maritza McIntyre | M | 58 | 5 años | |
David McGirr | M | 69 | 7 años | |
Simone Seiter | M | 57 | 7 años | |
Murray Stewart | M | 63 | 5 años | |
Elsy Boglioli Hofman | F | 42 | 4 años | |
Magali Taiel | M | - | 6 años | |
Bill Aliski | M | 75 | 5 años | |
Marion Ghibaudo | M | - | 3 años | |
Brian Bowersox | M | - | - | |
Christophe Arbet-Engels | M | - | 1 años | |
R. Woods | M | 56 | 1 años | |
Julio Benedicto | M | - | 7 años | |
Mark Baldry | M | 60 | 2 años | |
Art Taveras | M | 60 | 4 años | |
Cédric Moreau | M | 37 | 5 años | |
Timothy Walbert | M | 57 | 8 años | |
Scott Jeffers | M | - | 2 años |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Bernard Gilly | M | 67 | 12 años | |
René Russo | M | 49 | 6 años | |
Sean Nolan | M | 56 | 3 años | |
Philip Donenberg | M | 63 | 2 años | |
Bong Koh | M | - | - | |
Tamara Joseph | F | 61 |
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | 1 años |
Terrence Kearney | M | 69 | 2 años | |
Daniel Welch | M | 66 | 2 años | |
Paul Manning | M | 68 | 4 años | |
Derek Meisner | M | 53 | 3 años | |
Doug Treco Treco | M | 66 |
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | 17 años |
Kurt C. Gunter | M | 69 |
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | 5 años |
Brian K. Kaspar | M | - | - | |
Peter Goodfellow | M | 72 | 9 años | |
Natalie Mount | M | - | 4 años | |
Lisa Deschamps | F | 52 | 3 años | |
Frank Verwiel | M | 61 | 3 años | |
Fariborz Kamal | M | 61 | 1 años | |
Ronny Mosston | F | - | - | |
Isabelle Scarabin | F | - | 8 años | |
Craig Osten | M | - | - | |
Ross Moat | M | 43 | 1 años | |
Angela Thedinga | F | 42 | 1 años | |
Mihaela MacNair | F | - | 1 años | |
Philippe Motté | M | 64 | - | |
Shariq Ali | M | - | 2 años | |
Ritu Shah | F | 48 | 1 años | |
Karolyn Park | F | - | 1 años | |
Leigh Shaw | M | - | 2 años | |
Petra Kaufmann | M | 58 | 2 años | |
Robert May | M | 56 | 2 años | |
Sean Gaskell | M | 42 | 2 años | |
Clothilde Caillet | M | - | - | |
Diego Cadavid | M | 58 | 2 años | |
Obed M. Cepeda | M | - |
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | 1 años |
Thomas Gidoin | M | 41 | 9 años | |
William J. Fallon | M | - |
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | 3 años |
Thomas Sciascia | M | 70 |
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | 1 años |
Gregory Perry | M | 63 |
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | 2 años |
Neil Kirby | M | 63 |
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | - |
Konstantinos Andrikopoulos | M | 58 |
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | 3 años |
Daniel Geffken | M | 67 |
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | 6 años |
Jonathan Leff | M | 55 |
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | 5 años |
James Edward Thomas | M | 63 |
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | - |
Michael Astrue | M | 67 |
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | - |
Renato Fuchs | M | 80 |
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | 4 años |
Christoph Adams | M | 67 |
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | 7 años |
Rick Modi | M | 55 | 2 años | |
Shirish Hirani | M | - |
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | 3 años |
Joao Siffert | M | 60 | 1 años | |
Anthony S. Murabito | M | - |
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | 2 años |
Joseph Nolan | M | 61 | - | |
Ivana Magovcevic-Liebisch | M | 56 |
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | 3 años |
Sylvia Cheung | F | 50 |
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | 5 años |
Sukumar Nagendran | M | 58 | 3 años | |
R. Session | M | 45 | 1 años | |
Adi Mohanty | M | 57 |
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | 3 años |
Carrie Melvin | F | 56 | 2 años |
Estadísticas
País | Relaciones | % del total |
---|---|---|
Estados Unidos | 69 | 80.23% |
Francia | 19 | 22.09% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Françoise de Craecker
- Red Personal